|
|
Volumn 7, Issue 1, 2001, Pages 52-58
|
|
Autoimmune thyroid dysfunction induced by interferon-alfa treatment for chronic hepatitis C: Screening and monitoring recommendations
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',5' OLIGOADENYLATE SYNTHETASE;
ALPHA INTERFERON;
B LYMPHOCYTE DIFFERENTIATION FACTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA INTERFERON;
CELL PROTEIN;
GAMMA INTERFERON;
GLIPIZIDE;
IODINE 131;
LIOTHYRONINE;
LISINOPRIL;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
PROPYLTHIOURACIL;
RADIOACTIVE IODINE;
RECOMBINANT ALPHA INTERFERON;
RIBAVIRIN;
THYROID ANTIBODY;
THYROTROPIN;
THYROXINE;
VIRUS RNA;
ANTIVIRUS AGENT;
AUTOANTIBODY;
ADULT;
ARTICLE;
AUTOIMMUNE DISEASE;
CASE REPORT;
CHRONIC HEPATITIS;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CLINICAL OBSERVATION;
CONTROLLED STUDY;
DATA ANALYSIS;
DRUG MECHANISM;
FEMALE;
HEPATITIS C;
HUMAN;
HYPERTHYROIDISM;
HYPOTHYROIDISM;
IMMUNOMODULATION;
INCIDENCE;
LIVER FUNCTION;
MALE;
PATHOGENESIS;
PATIENT MONITORING;
PUBLICATION;
RADIOISOTOPE THERAPY;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SCREENING TEST;
THYROID DISEASE;
THYROID FUNCTION TEST;
THYROIDITIS;
TREATMENT INDICATION;
TREATMENT PLANNING;
BLOOD;
IATROGENIC DISEASE;
IMMUNOLOGY;
THYROID GLAND;
ADULT;
ANTIVIRAL AGENTS;
AUTOANTIBODIES;
AUTOIMMUNE DISEASES;
CASE REPORT;
FEMALE;
HEPATITIS C, CHRONIC;
HUMAN;
INTERFERON-ALPHA;
MALE;
MIDDLE AGE;
RISK FACTORS;
THYROID DISEASES;
THYROID GLAND;
|
|
EID: 0034846855
PISSN: 1530891X
EISSN: None
Source Type: Journal
DOI: 10.4158/ep.7.1.52 Document Type: Article |
|
Times cited : (34)
|
|
References (24)
|
